SWA11-ZZ-PE38

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSWA11-ZZ-PE38

Drug Alias Nameanti-CD24 fusion protein (Tel Aviv University)immunotherapy (Tel Aviv University)SWA11-ZZ-PE38

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionSignal transducer CD24 inhibitors

TargetsSignal transducer CD24

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTel Aviv University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTel Aviv University

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A